Unknown NA INTERVENTIONAL 2-arm NCT02113306

Does Transcutaneous Vagal Nerve Stimulation Improves Fear Extinction in Humans (t-VNSext)

Sponsor: KU Leuven

Updated 7 times since 2017 Last updated: Apr 11, 2014 Started: Jul 31, 2014 Primary completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy Adults, this trial is ongoing. The trial is conducted by KU Leuven and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Aug 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Jun 2018 — Aug 2018 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KU Leuven
Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium